BlackRock »

An2 Therapeutics shares owned by BlackRock

Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in An2 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including An2 Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in An2 Therapeutics by BlackRock

Quarter filed Position value Share count Share price at filing
2024-03-31 $946k 291k 3.25
2023-09-30 $678k 42k 16.08
2023-06-30 $200k 24k 8.50
2023-03-31 $4.8M 483k 9.87
2022-12-31 $4.2M 445k 9.53
2022-06-30 $1.4M 187k 7.73